Log in to save to my catalogue

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lun...

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8485a2ddff774172b10e1d66802a9ae3

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

About this item

Full title

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2021-02, Vol.20 (1), p.32-32, Article 32

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In the "precision oncology" era the characterization of tumor genetic features is a pivotal step in cancer patients' management. Liquid biopsy approaches, such as analysis of cell-free DNA from plasma, represent a powerful and noninvasive strategy to obtain information about the genomic status of the tumor. Sequencing-based analyses of cell-free DN...

Alternative Titles

Full title

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8485a2ddff774172b10e1d66802a9ae3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8485a2ddff774172b10e1d66802a9ae3

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-021-01327-5

How to access this item